Company Filing History:
Years Active: 2005-2010
Title: Innovations by Inventor Thomas E. Worthy in Cholesterol Measurement
Introduction: Thomas E. Worthy, an accomplished inventor based in Walnut Creek, California, has made significant contributions to the field of medical diagnostics. With a remarkable portfolio of 6 patents, Worthy's innovations focus on improving the accuracy and efficiency of cholesterol measurement in blood samples, which is critical for cardiovascular health assessment.
Latest Patents: Worthy's latest inventions include groundbreaking devices for cholesterol assays. One of his notable patents is the "High-density lipoprotein assay device and method," which allows for precise measurement of HDL-associated cholesterol. This assay design is particularly noteworthy for preventing interference from reagents, thereby ensuring accurate HDL quantification. Additionally, he developed an "Assay device for direct measurement of LDL cholesterol," leveraging selective precipitation and immunoseparation techniques. This device enables the entire assay to be conducted in a flow strip format, enhancing the practicality and speed of cholesterol testing.
Career Highlights: Thomas E. Worthy is currently affiliated with Cholestech Corporation, a company renowned for its innovations in cholesterol testing technologies. His work at Cholestech emphasizes the importance of reliable and efficient diagnostic tools in the healthcare landscape. Worthy's research has positioned him as a leader in the field of blood analysis, particularly for lipid profiling.
Collaborations: Throughout his career, Worthy has collaborated with esteemed professionals, including Jeffrey Shindelman and Anthony Joseph Nugent. These partnerships have undoubtedly contributed to the success of his inventions and the advancement of cholesterol assay methodologies.
Conclusion: Thomas E. Worthy's contributions to the medical diagnostics industry through his innovative cholesterol measurement devices represent a significant advancement in healthcare technology. His blend of expertise and collaboration continues to drive progress in lipid testing, making a profound impact on cardiovascular health management.